A detailed history of Viking Global Investors LP transactions in Pep Gen Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 1,482,434 shares of PEPG stock, worth $9.61 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,482,434
Previous 1,482,434 -0.0%
Holding current value
$9.61 Million
Previous $21.8 Million 8.57%
% of portfolio
0.09%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$8.94 - $16.39 $556,041 - $1.02 Million
-62,197 Reduced 4.03%
1,482,434 $13.3 Million
Q4 2022

Feb 14, 2023

SELL
$9.31 - $16.57 $2.32 Million - $4.13 Million
-249,292 Reduced 13.9%
1,544,631 $20.7 Million
Q2 2022

Aug 15, 2022

BUY
$9.0 - $12.89 $16.1 Million - $23.1 Million
1,793,923 New
1,793,923 $17.8 Million

Others Institutions Holding PEPG

About PepGen Inc.


  • Ticker PEPG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,631,900
  • Market Cap $153M
  • Description
  • PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...
More about PEPG
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.